참고문헌
- Christopher JM, Dean MD, John CW, Cameron DW, Henning AG, Hermes CG, et al. Esophageal leiomyoma: a 40-year experence. Ann Thorac Surg 2005;79:1122-5 https://doi.org/10.1016/j.athoracsur.2004.08.029
- Arnorsson T, Aberg C, Aberg T. Benign tumours of the oesophagus and oesophageal cyst. Scand J Thorac Surg 1984;18:145-50 https://doi.org/10.3109/14017438409102396
- Nguyen NT, Alcocer JJ, Luketich JD. Thoracoscopic enucleation of an esophageal leimyoma. J Clin Gastroenterol 2000; 31:89-90 https://doi.org/10.1097/00004836-200007000-00023
- Miettinen M, Sarlomo-Rikala M, Sobin LH, Lasota J. Esophageal stromal tumors: a clinicopathologic, immunohistochemical, and molecular genetic study of 17 cases and comparison with esophageal leiomyoma and leiomyosarcomas. Am J Surg Pathol 2000;24:211-22 https://doi.org/10.1097/00000478-200002000-00007
- Rosai J. GIST: an update. Int J Surg Pathol 2003;11:177-86 https://doi.org/10.1177/106689690301100304
- Pauwels EKJ, Ribeiro MJ, Stoot JHMB, McCready VR, Bourguignon M, Maziere B. FDG accumulation and tumor biology. Mini-review. Nucl Med Biol 1998;25:317-22 https://doi.org/10.1016/S0969-8051(97)00226-6
- Cook GJR, Fogelman I, Maisey MN. Normal physiological and benign pathological variants of 18-fluoro-2-deoxyglucose positronemission tomography scanning: potential for error in interpretation. Semin Nucl Med 1996; 26:308-14 https://doi.org/10.1016/S0001-2998(96)80006-7
- Gustavo SPM, Gregory R, Henry WDY, Timothy A. Esophageal leiomyoma:a rare cause of false positive FDG scans. Clin Nucl Med 2006;31:342-44 https://doi.org/10.1097/01.rlu.0000218771.35887.7a
- Kao CH. FDG uptake in a huge uterine myoma. Clin Nucl Med 2003;28:249 https://doi.org/10.1097/00003072-200303000-00025
- Ak I, Ozalp S, Yalcin OT, Zor E, Vardareli E. Uptake of 2- [18F]fluoro-2-deoxy-D-glucose in uterine leiomyoma: imaging of four patients by coincidence positron emission tomography. Nucl Med Comm 2004;25:941 https://doi.org/10.1097/00006231-200409000-00012
- Duo Q, Zhao Y, Tarnuzzer R, Rong H, William R, Schultz G, et al. Suppression of transforming growth factor-beta (TGF beta) and TGF beta receptor messenger ribonucleic acid and protein expression in leiomyomata in women receiving gonadotropin-releasing hormone agonist therapy. J Clin Endocrinol Metab 1996;81:3222-330 https://doi.org/10.1210/jc.81.9.3222
- Chegini N, Tang X, Ma C. Regulation of transforming growth factor-beta1 expression by granulocyte macrophage-colony-stimulating factor in leiomyoma and myometrial smooth muscle cells. J Clin Endocrinol Metab 1999;84:4138-43 https://doi.org/10.1210/jc.84.11.4138
- Mangrulkar R, Ono M, Ishikawa M, Takashima S, Klagsbrun M, Nowak R. Isolation and characterization of heparin-binding growth factors in human leiomyomas and normal myometrium. Bio Reprod 1995;53:363-46